Why Viking Therapeutics Stock Zoomed 5% Higher Today

Good news from a peer and a positive analyst update were the elements driving Viking Therapeutics (NASDAQ: VKTX) stock higher on the first trading day of the week.

The clinical-stage biotech, closely watched by some because of its investigational weight-loss drug VK2735, saw its share price improve by more than 5% as a result. By contrast, the S 500 index basically traded flat across the trading session.

The news driving Viking and other obesity drug developers came from a leading company in that space, Wegovy maker Novo Nordisk.

Source Fool.com